We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ovoca Bio Plc | LSE:OVB | London | Ordinary Share | IE00B4XVDC01 | EUR0.125 (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.00% | 0.75 | 0.70 | 0.80 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
0.75 | 0.75 | 0.75 | 0.00 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.46M | -5.61M | -0.0688 | -0.11 | 611.73k |
Date | Time | Source | Headline |
---|---|---|---|
23/1/2024 | 07:00 | UKREG | Ovoca Bio PLC Holding(s) in Company |
01/12/2023 | 12:00 | UKREG | Ovoca Bio PLC Result of AGM |
07/11/2023 | 09:15 | UKREG | Ovoca Bio PLC Notice of AGM |
28/9/2023 | 14:41 | ALNC | EARNINGS: Ovoca "to adapt" after study let-down, Kelso NAV rises |
28/9/2023 | 07:00 | UKREG | Ovoca Bio PLC Interim Results |
31/8/2023 | 12:08 | ALNC | Ovoca Bio shares dive following disappointing Orenetide study results |
31/8/2023 | 07:00 | UKREG | Ovoca Bio PLC Summary Results of Phase II Study for Orenetide |
30/6/2023 | 17:26 | ALNC | EARNINGS SUMMARY: Powerhouse loss widens hugely, DCI Advisors narrows |
30/6/2023 | 07:00 | UKREG | Ovoca Bio PLC Annual Financial Report |
12/6/2023 | 09:01 | ALNC | Ovoca Bio shares down as study delayed due to staffing issues |
1 Year Ovoca Bio Chart |
Intraday Ovoca Bio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions